FDA Approves PRRT to Treat Neuroendocrine Tumors
source: pixabay.com

FDA Approves PRRT to Treat Neuroendocrine Tumors

  Patients with inoperable or metastasized neuroendocrine tumors (NETs) may now benefit from recently FDA approved peptide receptor radionuclide therapy (PRRT) according to a recent article in MedPage Today. The…

Continue Reading FDA Approves PRRT to Treat Neuroendocrine Tumors
FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors
source: pixabay.com

FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors

  Surufatinib was recently granted Orphan Drug designation by the FDA. This drug was made for the treatment of pancreatic neuroendocrine tumors (PanNETs). It was created by Hutchison China MediTech…

Continue Reading FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors
Phase 1 Trial of Experimental Treatment for Neuroendocrine Tumors Begins
bdyczewski / Pixabay

Phase 1 Trial of Experimental Treatment for Neuroendocrine Tumors Begins

According to a story from Central Charts, the drug developer Crinetics Pharmaceuticals, Inc. recently issued an announcement revealing that the company has begun the initialization of a Phase 1 clinical…

Continue Reading Phase 1 Trial of Experimental Treatment for Neuroendocrine Tumors Begins

New Treatment for GEP-NETs Approved in Canada

According to a story from pm360online.com, the Novartis company Advanced Accelerator Applications S.A. recently announced that Health Canada has issued approval for Lutathera™ as a treatment for gasteroenteropancreatic neuroendocrine tumors…

Continue Reading New Treatment for GEP-NETs Approved in Canada
FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!
source: pixabay.com

FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!

Neuroendocrine tumors are growths which form from neuroendocrine cells in various places throughout the body. They can occur in the gastrointestinal track, the pancreas, the lungs, the thymus, and other…

Continue Reading FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!

Powerlifter to Compete again in World Championships Despite Rare Diagnosis

Joe Marksteiner, a 22-year Air Force veteran and former gymnast, won a title at the 2013 World Powerlifting Championships at the age of 60. This year, now at 65, he…

Continue Reading Powerlifter to Compete again in World Championships Despite Rare Diagnosis
What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors
IADE-Michoko / Pixabay

What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors

On August 16th, 2018, Aretha Franklin, the "Queen of Soul," passed away at age 76. Aretha will be immortalized for generations because of the success of her classic soul ballads…

Continue Reading What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors
A New App has Been Developed to Support the Neuroendocrine Tumour Community
JESHOOTScom / Pixabay

A New App has Been Developed to Support the Neuroendocrine Tumour Community

Novartis has teamed up with Numinous Games to develop Galaxies of Hope, an app that is designed to support the neuroendocrine tumour (NET) community. You can read the original source…

Continue Reading A New App has Been Developed to Support the Neuroendocrine Tumour Community
Close Menu